IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v537y2016i7619d10.1038_nature19112.html
   My bibliography  Save this article

Structure-based discovery of opioid analgesics with reduced side effects

Author

Listed:
  • Aashish Manglik

    (Stanford University School of Medicine)

  • Henry Lin

    (University of California)

  • Dipendra K. Aryal

    (UNC Chapel Hill Medical School)

  • John D. McCorvy

    (UNC Chapel Hill Medical School)

  • Daniela Dengler

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Gregory Corder

    (Perioperative and Pain Medicine, Neurosurgery, Stanford Neurosciences Institute, Stanford University School of Medicine)

  • Anat Levit

    (University of California)

  • Ralf C. Kling

    (Friedrich-Alexander-Universität Erlangen-Nürnberg
    Institut für Physiologie und Pathophysiologie, Paracelsus Medical University)

  • Viachaslau Bernat

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Harald Hübner

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Xi-Ping Huang

    (UNC Chapel Hill Medical School)

  • Maria F. Sassano

    (UNC Chapel Hill Medical School)

  • Patrick M. Giguère

    (UNC Chapel Hill Medical School)

  • Stefan Löber

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Da Duan

    (University of California)

  • Grégory Scherrer

    (Stanford University School of Medicine
    Perioperative and Pain Medicine, Neurosurgery, Stanford Neurosciences Institute, Stanford University School of Medicine)

  • Brian K. Kobilka

    (Stanford University School of Medicine)

  • Peter Gmeiner

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Bryan L. Roth

    (UNC Chapel Hill Medical School)

  • Brian K. Shoichet

    (University of California)

Abstract

Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side effects of morphine and related opioids—which include fatal respiratory depression—are thought to be mediated by μ-opioid-receptor (μOR) signalling through the β-arrestin pathway or by actions at other receptors. Conversely, G-protein μOR signalling is thought to confer analgesia. Here we computationally dock over 3 million molecules against the μOR structure and identify new scaffolds unrelated to known opioids. Structure-based optimization yields PZM21—a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment. Unlike morphine, PZM21 is more efficacious for the affective component of analgesia versus the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses. PZM21 thus serves as both a probe to disentangle μOR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.

Suggested Citation

  • Aashish Manglik & Henry Lin & Dipendra K. Aryal & John D. McCorvy & Daniela Dengler & Gregory Corder & Anat Levit & Ralf C. Kling & Viachaslau Bernat & Harald Hübner & Xi-Ping Huang & Maria F. Sassano, 2016. "Structure-based discovery of opioid analgesics with reduced side effects," Nature, Nature, vol. 537(7619), pages 185-190, September.
    • Handle: RePEc:nat:nature:v:537:y:2016:i:7619:d:10.1038_nature19112
    DOI: 10.1038/nature19112
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature19112
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature19112?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Justine S. Paradis & Xiang Feng & Brigitte Murat & Robert E. Jefferson & Badr Sokrat & Martyna Szpakowska & Mireille Hogue & Nick D. Bergkamp & Franziska M. Heydenreich & Martine J. Smit & Andy Chevig, 2022. "Computationally designed GPCR quaternary structures bias signaling pathway activation," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    2. Kouki Kawakami & Masataka Yanagawa & Suzune Hiratsuka & Misaki Yoshida & Yuki Ono & Michio Hiroshima & Masahiro Ueda & Junken Aoki & Yasushi Sako & Asuka Inoue, 2022. "Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    3. Lin Cheng & Zhuang Miao & Sicen Liu & Zhe Li & Hong Fu & Chanjuan Xu & Shilong Hu & Chang Zhao & Yuxuan Liu & Tiantian Zhao & Wencheng Liu & Heli Wang & Runduo Liu & Wei Yan & Xiangdong Tang & Jianfen, 2024. "Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    4. Jun Yu & Amit Kumar & Xuefeng Zhang & Charlotte Martin & Kevin Van holsbeeck & Pierre Raia & Antoine Koehl & Toon Laeremans & Jan Steyaert & Aashish Manglik & Steven Ballet & Andreas Boland & Miriam S, 2024. "Structural basis of μ-opioid receptor targeting by a nanobody antagonist," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    5. Amal El Daibani & Joseph M. Paggi & Kuglae Kim & Yianni D. Laloudakis & Petr Popov & Sarah M. Bernhard & Brian E. Krumm & Reid H. J. Olsen & Jeffrey Diberto & F. Ivy Carroll & Vsevolod Katritch & Bern, 2023. "Molecular mechanism of biased signaling at the kappa opioid receptor," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    6. Björn D. M. Bean & Colleen J. Mulvihill & Riddhiman K. Garge & Daniel R. Boutz & Olivier Rousseau & Brendan M. Floyd & William Cheney & Elizabeth C. Gardner & Andrew D. Ellington & Edward M. Marcotte , 2022. "Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:537:y:2016:i:7619:d:10.1038_nature19112. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.